Clinical Studies and Case Reports

On this site you will find clinical studies with cannabis or single cannabinoids in different diseases and case reports on the use of cannabis by patients.
You may search for diseases (indications), authors, medication, study design (controlled study, open trial, case report etc.) and other criteria.




[Back to Overview]  [IACM Homepage]

TitleDronabinol stimulates appetite and causes weight gain in HIV patients.
Author(s)Plasse T, Conant M, Gorter R, Shepard KV
Journal, Volume, IssueInternational Conference on AIDS 1992;8(3):122 (abstract no. PuB 7442)
Major outcome(s)increase in appetite, trend toward weight gain
IndicationHIV/AIDS; Appetite loss/weight loss; DepressionAbstract
MedicationDelta-9-THC

OBJECTIVE: To test the effect of dronabinol (delta-9- tetrahydrocannabinol) on appetite and weight in symptomatic HIV patients (pts). METHODS: Forty pts with symptomatic HIV infection who were actively losing weight were entered into this dose ranging study of dronabinol (Marinol, Roxane Laboratories, Columbus OH). After a one week baseline period, pts were treated for 4 weeks; to be evaluable for efficacy, patients had to receive at least 3 weeks' medication. Pts were weighed and completed a questionnaire on physical and psychological symptoms weekly; they completed 100mm visual analog scales for hunger before each meal. Of 40 pts entered, 10 withdrew due to suspected adverse effects of study medication and 7 due to other causes. RESULTS: TABULAR DATA, SEE ABSTRACT VOLUME. CONCLUSIONS: In this open pilot study, dronabinol 2.5 mg bid was well tolerated and caused a significant increase in appetite, improvement of symptoms and a strong trend toward weight gain.

Route(s)Oral
Dose(s)2.5 mg twice daily
Duration (days)28
Participants40 patients with AIDS
DesignControlled study
Type of publication
Address of author(s)UNIMED Inc., Somerville, NJ., USA
Full text

[Back to Overview]  [IACM Homepage]


up